Coherus Biosciences | Stammkapital

Aktienkurs
1.63
Täglich Wechseln
-0.08 -4.68%
Monatlich
-0.61%
Jährlich
52.34%
Q1 Prognose
1.58




Stammkapital Veränderung Datum
AbbVie USD 1.77B 1.75B 2025-06
Acadia Pharmaceuticals USD 168.71M 104K 2025-09
Akebia Therapeutics USD 2K 0 2025-03
ALKERMES USD 165.1M 49K 2025-09
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Amarin USD 20.8M 28K 2025-09
Amgen USD 539M 1000K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Coherus Biosciences USD 12K 0 2025-03
Eli Lilly USD 946.83M 354.23M 2025-06
Fujifilm JPY 1.21B 19K 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
Merck USD 2.49B 15.79M 2025-09
Myriad Genetics USD 93.1M 0 2025-09
Pacira USD 44.9M 44.85M 2025-06
Perrigo USD 137.6M 0 2025-09
Pfizer USD 5.69B 1000K 2025-09
PTC Therapeutics USD 81.47M 1.54M 2025-12
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
Vertex Pharmaceuticals USD 254M 0 2025-12
Xencor USD 71.34M 46K 2025-09
Zoetis USD 424.93M 16.54M 2025-12


Coherus Biosciences Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.